Previous studies have revealed that IL-34 is expressed in synovium, and the increased IL-34 levels in serum and synovial fluid (SF) are associated with synovitis severity and disease progression in rheumatoid arthritis (RA) patients [7–9]. The gene discussed is IL34; the disease is rheumatoid arthritis.